132 related articles for article (PubMed ID: 10644881)
1. Selective induction of MCP-1 in human mesangial cells by the IL-6/sIL-6R complex.
Coletta I; Soldo L; Polentarutti N; Mancini F; Guglielmotti A; Pinza M; Mantovani A; Milanese C
Exp Nephrol; 2000; 8(1):37-43. PubMed ID: 10644881
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells.
Schwarz M; Radeke HH; Resch K; Uciechowski P
Kidney Int; 1997 Dec; 52(6):1521-31. PubMed ID: 9407497
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells.
Zoja C; Wang JM; Bettoni S; Sironi M; Renzi D; Chiaffarino F; Abboud HE; Van Damme J; Mantovani A; Remuzzi G
Am J Pathol; 1991 Apr; 138(4):991-1003. PubMed ID: 2012180
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
[TBL] [Abstract][Full Text] [Related]
6. Cytokine regulation of CC and CXC chemokine expression by human astrocytes.
Oh JW; Schwiebert LM; Benveniste EN
J Neurovirol; 1999 Feb; 5(1):82-94. PubMed ID: 10190694
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
8. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.
Marin V; Montero-Julian FA; Grès S; Boulay V; Bongrand P; Farnarier C; Kaplanski G
J Immunol; 2001 Sep; 167(6):3435-42. PubMed ID: 11544336
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and the soluble interleukin-6 receptor induce stem cell factor and Flt-3L expression in vivo and in vitro.
Peters M; Solem F; Goldschmidt J; Schirmacher P; Rose-John S
Exp Hematol; 2001 Feb; 29(2):146-55. PubMed ID: 11166453
[TBL] [Abstract][Full Text] [Related]
10. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10.
Duque N; Gómez-Guerrero C; Egido J
J Immunol; 1997 Oct; 159(7):3474-82. PubMed ID: 9317146
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6.
Sawada S; Chosa N; Ishisaki A; Naruishi K
Biomed Res; 2013 Feb; 34(1):31-40. PubMed ID: 23428978
[TBL] [Abstract][Full Text] [Related]
12. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
13. c-Rel and p65 trans-activate the monocyte chemoattractant protein-1 gene in interleukin-1 stimulated mesangial cells.
Stylianou E; Nie M; Ueda A; Zhao L
Kidney Int; 1999 Sep; 56(3):873-82. PubMed ID: 10469356
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
[TBL] [Abstract][Full Text] [Related]
15. [Curcumin inhibited the proliferation and extracellular matrix production of human mesangial cells].
Bao HY; Chen RH; Huang SM; Pan XQ; Fei L
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):822-6. PubMed ID: 14728887
[TBL] [Abstract][Full Text] [Related]
16. The soluble form of interleukin-6 receptor modulates cell proliferation by acute myeloblastic leukemia blast cells.
Säily M; Koistinen P; Savolainen ER
Ann Hematol; 1999 Apr; 78(4):173-9. PubMed ID: 10348148
[TBL] [Abstract][Full Text] [Related]
17. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.
Klouche M; Bhakdi S; Hemmes M; Rose-John S
J Immunol; 1999 Oct; 163(8):4583-9. PubMed ID: 10510402
[TBL] [Abstract][Full Text] [Related]
18. Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets.
Marino M; Scuderi F; Ponte E; Maiuri MT; De Cristofaro R; Provenzano C; Rose-John S; Cittadini A; Bartoccioni E
J Biol Regul Homeost Agents; 2013; 27(3):841-52. PubMed ID: 24152848
[TBL] [Abstract][Full Text] [Related]
19. Exogenous nitric oxide inhibits tumor necrosis factor-alpha- or interleukin-1-beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells. Role of IkappaB-alpha and cyclic GMP.
Lee SK; Kim CS; Yang WS; Kim SB; Park SK; Park JS
Nephron; 2002 Dec; 92(4):780-7. PubMed ID: 12399621
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR
Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
